content_top
43 companies, 1 interpreter! Insight, foresight
and recommendation 

Biostage (BSTG)

0.32
-0.00
(-1.09%)
Sep 11, 4:00PM EDT
content_middle

Biostage ™ is a biotechnology company in the emerging field of regenerative medicine. Its goal is to regenerate and restore organ function of the esophagus, trachea or bronchus damaged by cancer, trauma, infection or congenital diseases.  BSTG’s Cellframe™ technology is engineered to stimulate the body’s signaling pathways and natural healing process to regenerate and restore organ function. Our Cellframe technology is based on over 20 years of scientific progress in the fields of tissue engineering, cell biology and material science. Cellframe technology combines the best attributes of a synthetic scaffold with tissue engineering and cell biology to create what may be a revolutionary method of addressing organ damage.

Previous Close: 
0.32
Open: 
0.32
Bid: 
0.31
Ask: 
0.34
1yr Target Price: 
3.00
Day's Range: 
0.31 - 0.33
52wk Range: 
0.22 - 1.42
Volume: 
397243
Average Daily Volume: 
1364120
Market Capitalization: 
12.32M
Trailing Annual Dividend Yield: 
N/A
Shares Outstanding: 
38933000M